These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6095548

  • 1. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E.
    Z Gesamte Inn Med; 1984 Sep 01; 39(17):414-7. PubMed ID: 6095548
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E, Rosenthaler J.
    Eur J Pharmacol; 1983 Apr 22; 89(1-2):1-8. PubMed ID: 6861880
    [Abstract] [Full Text] [Related]

  • 9. [Comparative responsiveness of isolated saphenous, femoral and external carotid arteries and veins of dogs to dihydroergotamine mesylate (DEM) (author's transl)].
    Fukawa K, Honda H, Kubota H, Hatanaka Y, Sawabe T.
    Nihon Yakurigaku Zasshi; 1981 Sep 22; 78(3):223-30. PubMed ID: 7327451
    [Abstract] [Full Text] [Related]

  • 10. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD.
    Headache; 1997 Sep 22; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of dihydrolysergic acid amide on serotonergic and alpha-adrenergic receptors in human blood platelets and femoral veins in vitro.
    Glusa E, Markwardt F.
    Arch Int Pharmacodyn Ther; 1986 Oct 22; 283(2):303-11. PubMed ID: 3024599
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological actions of the main metabolites of dihydroergotamine.
    Müller-Schweinitzer E.
    Eur J Clin Pharmacol; 1984 Oct 22; 26(6):699-705. PubMed ID: 6489409
    [Abstract] [Full Text] [Related]

  • 14. Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.
    Nilsson F, Nilsson T, Edvinsson L, Björkman S, Nordström CH.
    Acta Anaesthesiol Scand; 1997 Nov 22; 41(10):1257-62. PubMed ID: 9422289
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro studies on the duration of action of dihydroergotamine.
    Müller-Schweinitzer E.
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov 22; 18(2):88-91. PubMed ID: 7372380
    [Abstract] [Full Text] [Related]

  • 19. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G, Verwaerde P, Pathak A, Tran MA, Montastruc JL, Senard JM.
    Fundam Clin Pharmacol; 2007 Feb 22; 21(1):45-53. PubMed ID: 17227444
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.